Follow The Bouncing Ball: Barack Obama and The PhRMA Deal

Paul Blumenthal, over at the Sunlight Foundation, has done a deep dive into public records detailing the close relationship between the White House and PhRMA, the drug lobby powerhouse that Obama used as Example A of what was wrong with politics in 2008. As is the habit of modern Internet work, he introduces his journalism with an overview video:

UPDATE: Billy Tauzin Out at PhRMA

News broke overnight that Billy Tauzin, the Democratic congressman turned Republican turned lobbyist, was stepping down as head of the the Pharmaceutical Research and Manufacturers of America. Tauzin led the group when it struck a mid-2009 backroom deal with President Obama and the chair of the Senate Finance Committee. The deal, according to published reports, [...]

Amidst the Lieberman Drama, Some Wrangling Over Drug Prices

Tonight the Senate began voting on amendments to the health care bill for the first time in days. Near the top of the agenda: an amendment from Democratic Sen. Byron Dorgan that would have allowed U.S. pharmacies and drug wholesalers to “reimport” drugs from foreign countries. It was was voted down 51-48. (Amendments need 60 [...]

Is the Public Option Dead? Plus, Amendments That Might Actually Matter

The Associated Press and New York Times are reporting tonight that the 10 senators tapped to negotiate an alternative to or compromise on the Senate health reform bill’s public option have dropped the idea of a government-run health insurance plan altogether. Senate Majority Leader Harry Reid told reporters that the group is sending proposals to [...]

HEALTH REFORM: The Drug Industry’s Sweetheart Deal

It turns out that spending $609,000 a day on lobbying can be a great investment. Health reform is looking to be very, very good for the pharmaceutical business. Jon Cohn has new evidence on why we should take their complaints about the bill with two aspirin–and a grain of salt.

Finance Committee Democrats Buck the White House

For the most part, 13-10 vote tallies on the Senate Finance Committee’s heath reform bill this week will be strictly along party lines. There are 13 Democrats on the committee, including Chairman Max Baucus, and 10 Republicans. But a 13-10 divide this afternoon on an amendment from Democrat Bill Nelson indicated a different kind of [...]

Obama and PhRMA: Deal or No Deal?

Yesterday’s New York Times report of a behind-the-scenes deal between the White House and the drug lobby is causing no small degree of consternation among Democrats on Capitol Hill. Over at HuffPost, Ryan Grim is reporting that Senators received assurances from the White House that there was no deal that would prevent Medicare from negotiating [...]